Adrenal glucocorticoids modulate [3H]cyclic AMP binding to protein kinase A (PKA), cyclic AMP-dependent PKA activity, and protein levels of selective regulatory and catalytic subunit isoforms of PKA in rat brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 1, 2000, Pages 103-116

  Dwivedi, Yogesh ^a   Pandey, Ghanshyam N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOCORTICOID;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOOD; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

EID: 0033942985     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Benovic JL, Bouvier M, Caron MG and Lefkowitz RJ (1988) Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu Rev Cell Biol 4:405-428.
2. Borrelli E, Montmayeur JP, Foulkes NS and Sassone-Corsi P (1992) Signal transduction and gene control: The cAMP pathway. Crit Rev Oncog 3:321-338.
3. Brandon EP, Logue SF, Adams MR, Qi M, Sullivan SP, Matsumoto AM, Dorsa DM, Wehner JM, McKnight GS and Idzerda RL (1998) Defective motor behavior and neural gene expression in RIIβ-protein kinase A mutant mice. J Neurosci 18: 3639-3649.
4. Builder SE, Beavo JA and Krebs EG (1980) Stoichiometry of cAMP and 1,N6-etheno-cAMP binding to protein kinase. J Biol Chem 255:2350-2354.
5. 3 cells. Endocrinology 121:1711-1715.
6. Chaouloff F (1995) Regulation of 5HT receptors by corticosteroids: Where do we stand? Fundam Clin Pharmacol 9:219-233.
7. Clegg CH and McKnight GS (1988) Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 85:3703-3707.
8. Duman RS, Strada SJ and Enna SJ (1989) Glucocorticoid administration increases receptor-mediated and forskolin-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices. Brain Res 477:166-171.
9. 3H]cyclic AMP binding sites and PKA activity in the prefrontal cortex of suicide subjects. Abstr Soc Neurosci 25:2097.
10. Dwivedi Y and Pandey GN (1999a) Administration of dexamethasone up-regulates protein kinase C activity and the expression of γ and ε protein kinase C isozymes in the rat brain. J Neurochem 72:380-387.
11. 1 isozyme in rat brain. J Neurochem 73:780-790.
12. 2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 22:477-491.
13. Fischer TH, Campbell KP and White GC II (1987) An investigation of functional similarities between the sarcoplasmic reticulum and platelet calcium-dependent adenosinetriphosphatases with the inhibitors quercetin and calmidazolium. Biochemistry 26:8024.
14. Flockhart DA and Corbin JD (1982) Regulatory mechanisms in the control of protein kinases. CRC Crit Rev Biochem 12:133-186.
15. Francis SH and Corbin JD (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 56:237-272.
16. Galas M-C and Harden TK (1995) Receptor-induced heterologous desensitization of receptor-regulated phospholipase C. Eur J Pharmacol 291:175-182.
17. Gannon MN and McEwen BS (1990) Calmodulin involvement in stress and corticosterone-induced downregulation of cyclic AMP-generating systems in brain. J Neurochem 55:276-284.
18. Gettys TW and Corbin CJ (1989) The protein kinase family of enzymes, in Receptor Phosphorylation (Moudgil VK ed) pp 40-88, CRC Press, Boca Raton, FL.
19. Glass DB, Cheng HC, Mende-Mueller L, Reed J and Walsh DA ( (1989) Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem 264:8802-8810.
20. Halbreich U, Asnis GM, Shindledecker R, Zumoff B and Nathan RS (1985) Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry 42:904-908.
21. Harrelson AL and McEwen BS (1987) Hypophysectomy increases vasoactive intestinal peptide-stimulated cyclic AMP generation in the hippocampus of the rat. J Neurosci 7:2807-2810.
22. Holsboer F, Lauer CJ, Schreiber W and Krieg JC (1995) Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62:340-347.
23. Johnson GS and Jaworski CJ (1983) Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts. Mol Pharmacol 23:648-652.
24. Kemp BE, Graves DJ, Benjamini E and Krebs EG (1977) Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem 252:4888-4894.
25. Leiser M, Rubin CS and Erlichman J (1986) Differential binding of the regulatory subunit (RII) of cAMP-dependent protein kinase II from bovine brain and muscle to RH-binding proteins. J Biol Chem 261:1904-1908.
26. Ling MHM, Perry PJ and Tsuang MT (1981) Side effects of corticosteroid therapy: Psychiatric aspects. Arch Gen Psychiatry 38:471-477.
27. Lowry OH, Rosebrough NJ, Farr AL and Handall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265-275.
28. Maes M, Vandervorst C, Suy E, Minner B and Raus J (1991) A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and β-endorphin in melancholic patients. Acta Psychiatr Scand 83:480-491.
29. Manier DH, Eiring A, Shelton RC and Sulser F (1996) (β-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression. Neuropsychopharmacology 15:555-561.
30. McEwen BS (1987) Glucocorticoid-biogenic amine interactions in reaction to mood and behaviour. Biochem Pharmacol 36:1755-1763.
31. McPherson GA (1985) Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J Pharmacol Methods 14:213-228.
32. Milligan G (1993) Agonist regulation of cellular G protein levels and distribution: Mechanisms and functional implications Trends Pharmacol Sci 14:413-418.
33. Mobley PL, Manier DH and Sulser F (1983) Norepinephrine-sensitive adenylate cyclase system in rat brain: Role of adrenal corticosteroids. J Pharmacol Exp Ther 226:71-77.
34. Murphy BEP (1991) Steroids and depression. J Steroid Biochem Mol Biol 38:537-559.
35. Nestler EJ and Greengard P (1994) Protein phosphorylation and the regulation of neuronal function, in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects (Siegel GH, Albers RW, Agranoff BW and Molinoff P eds) pp 449-474, Little, Brown, Boston.
36. oα immunoreactivities in left temporal cortices from patients with schizophrenia. Brain Res 615:41-49.
37. 3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J Neurochem 68:297-304.
38. Rodan SB and Rodan GA (1986) Dexamethasone effects on β adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells. Endocrinology 118:2510-2518.
39. iα messenger RNA and protein in rat cerebral cortex. Proc Natl Acad Sci USA 86:3906-3910.
40. Sarkar D, Erlichman J and Rubin CS (1984) Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II. J Biol Chem 259:9840-9846.
41. Scott JD, Glaccum MB, Zoller MJ, Uhler MD, Helfman DM, McKnight GS and Krebs EG (1987) The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain. Proc Natl Acad Sci USA 84:5192-5196.
42. Shelton RC, Mainer DH and Sulser F (1996) cAMP-dependent protein kinase activity in major depression. Am J Psychiatry 153:1037-1042.
43. Showers MO and Maurer RA (1986) A cloned bovine cDNA encodes an alternate form of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem 261: 16288-16291.
44. Smith MK, Colbran RJ and Soderling TR (1990) Specificities of autoinhibitory domain peptides for four protein kinases. Implications for intact cell studies of protein kinase function J Biol Chem 265:1837-1840.
45. Spaulding SW (1993) The ways in which hormones change cyclic adenosine 3′,5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr Rev 14:632-650.
46. Uhler MD, Chrivia JC and McKnight GS (1986) Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem 261:15360-15363.
47. Van de Kar LD (1989) Neuroendocrine aspects of the serotonergic hypothesis of depression. Neurosci Biobehav Rev 13:237-246.
48. Wen W, Harootunian AT, Adams SR, Feramisco J, Tsien RY, Meinkoth JL and Taylor SS (1994) Heat-stable inhibitors of cAMP-dependent protein kinase carry a nuclear export signal. J Biol Chem 269:32214-32220.
49. Witt JJ and Roskoski R Jr (1975) Rapid protein kinase assay using phosphocellulose-paper absorption. Anal Biochem 66:253-258.
50. Wolkowitz OM and Reus VI (1999) Treatment of depression with antiglucocorticoid drugs. Psychosom Med 61:698-711.
51. 1A receptors by corticosteroid hormones. Brain Res Mol Brain Res 29:23-34.